Your browser doesn't support javascript.
loading
biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis (ADAPT-Sepsis): A protocol for a multicentre randomised controlled trial.
Dark, Paul; Perkins, Gavin D; McMullan, Ronan; McAuley, Danny; Gordon, Anthony C; Clayton, Jonathan; Mistry, Dipesh; Young, Keith; Regan, Scott; McGowan, Nicola; Stevenson, Matt; Gates, Simon; Carlson, Gordon L; Walsh, Tim; Lone, Nazir I; Mouncey, Paul R; Singer, Mervyn; Wilson, Peter; Felton, Tim; Marshall, Kay; Hossain, Anower M; Lall, Ranjit.
Afiliação
  • Dark P; Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Critical Care Unit, Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Greater Manchester, UK.
  • Perkins GD; Warwick Medical School, Clinical Trials Unit, University of Warwick, Coventry, UK.
  • McMullan R; Wellcome Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, UK.
  • McAuley D; Wellcome Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, UK.
  • Gordon AC; Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, UK.
  • Clayton J; Clinical Biochemistry Department, Lancashire Teaching Hospitals NHS Foundation Trust, Sharoe Green Lane, Fulwood, Preston Lancashire, UK.
  • Mistry D; Warwick Medical School, Clinical Trials Unit, University of Warwick, Coventry, UK.
  • Young K; Warwick Medical School, Clinical Trials Unit, University of Warwick, Coventry, UK.
  • Regan S; Warwick Medical School, Clinical Trials Unit, University of Warwick, Coventry, UK.
  • McGowan N; Warwick Medical School, Clinical Trials Unit, University of Warwick, Coventry, UK.
  • Stevenson M; School of Health and Related Research, The University of Sheffield Western Bank, Sheffield, UK.
  • Gates S; Cancer Research Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
  • Carlson GL; National Intestinal Failure Centre, Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Greater Manchester, UK.
  • Walsh T; Anaesthesia, Critical Care and Pain Medicine, Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh Royal Infirmary, Edinburgh, UK.
  • Lone NI; Anaesthesia, Critical Care and Pain Medicine, Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh Royal Infirmary, Edinburgh, UK.
  • Mouncey PR; Clinical Trials Unit, Intensive Care National Audit and Research Centre, Napier House, London, UK.
  • Singer M; Centre for Intensive Care Medicine, Experimental and Translational Medicine, Division of Medicine, Faculty of Medical Sciences, University College London, London, UK.
  • Wilson P; Clinical Microbiology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Felton T; Respiratory Academic Group, Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Wythenshawe Hospital, Manchester, UK.
  • Marshall K; Pharmacy and Pharmaceutical Sciences, School of Health Sciences, University of Manchester, Manchester, UK.
  • Hossain AM; Warwick Medical School, Clinical Trials Unit, University of Warwick, Coventry, UK.
  • Lall R; Warwick Medical School, Clinical Trials Unit, University of Warwick, Coventry, UK.
J Intensive Care Soc ; 24(4): 427-434, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37841304

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Intensive Care Soc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Intensive Care Soc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido